The CXCL12-CXCR4 axis in colorectal cancer: immune regulation, metastatic progression, and therapeutic implications

作者
Shuanglin Tian,Jinrui Liu,Xiulan Yang,Jiawei Guo
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:17: 1783222-1783222 被引量:5
标识
DOI:10.3389/fimmu.2026.1783222
摘要

Metastasis remains the major cause of mortality in colorectal cancer (CRC) despite continued advances in diagnosis and treatment. Increasing evidence identifies the CXCL12/CXCR4 chemokine axis as a critical driver of CRC progression and metastatic dissemination. Through dynamic interactions between tumor cells and the tumor microenvironment, this axis regulates multiple processes essential for metastasis, including driving migration and invasion, angiogenesis and lymphangiogenesis, and shaping the tumor immune microenvironment through recruitment of immunosuppressive populations, blockade of effector lymphocyte trafficking and function, and modulation of immunosuppressive cytokines including IL-10. In this review, we summarize the molecular mechanisms by which CXCL12/CXCR4 promotes CRC metastasis. These pleiotropic effects are mediated by crosstalk with PI3K/Akt, MAPK/ERK, and Wnt/β-catenin pathways, and are regulated at transcriptional, post-transcriptional, and post-translational levels. Preclinical studies demonstrate that CXCR4 antagonists (e.g., plerixafor, LY2510924) suppress metastasis and, when combined with immune checkpoint inhibitors, can reverse the "cold" immune phenotype of microsatellite-stable CRC. We also discuss recent advances in the regulation of CXCL12/CXCR4 expression, the role of related receptors such as CXCR7, and emerging strategies targeting this axis for therapeutic intervention. Collectively, current evidence supports the CXCL12/CXCR4 axis as a promising biomarker and therapeutic target in metastatic CRC, and further elucidation of its regulatory network may facilitate the development of more effective precision treatment strategies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
碧蓝的睫毛完成签到,获得积分10
刚刚
Phil丶完成签到,获得积分10
刚刚
文艺的文龙完成签到,获得积分10
1秒前
july7292发布了新的文献求助10
1秒前
夏日的羊屁屁完成签到,获得积分10
1秒前
albbxmy完成签到,获得积分10
1秒前
CipherSage的应助被Caicai采纳,获得10
1秒前
bkagyin的应助被yaya采纳,获得10
1秒前
星星完成签到 ,获得积分10
1秒前
Www完成签到,获得积分10
2秒前
Orange的应助被dzh采纳,获得10
2秒前
学术牛马完成签到,获得积分10
2秒前
小马甲的应助被mkl采纳,获得10
2秒前
美好眼神完成签到,获得积分10
2秒前
2秒前
obito发布了新的文献求助10
2秒前
动听无声完成签到,获得积分10
2秒前
3秒前
3秒前
tyx发布了新的文献求助10
3秒前
宫冷雁完成签到 ,获得积分10
3秒前
叨叨小夫夫完成签到,获得积分10
3秒前
踏实采波完成签到,获得积分10
3秒前
我真的晕发布了新的文献求助10
4秒前
wlj发布了新的文献求助10
4秒前
4秒前
慕晓发布了新的文献求助10
4秒前
orixero的应助被Circle采纳,获得10
4秒前
yl666完成签到,获得积分10
4秒前
小鱼肖恩完成签到,获得积分10
4秒前
kingfisher完成签到,获得积分10
4秒前
英姑的应助被霁月采纳,获得10
4秒前
医只兔完成签到,获得积分10
4秒前
方超完成签到,获得积分10
4秒前
科研通AI6.4的应助被Yue采纳,获得10
5秒前
Owen的应助被Yue采纳,获得10
6秒前
遇见发布了新的文献求助10
6秒前
你的女孩TT完成签到,获得积分10
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185